Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
28/03/2025 15:26
March 28 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd 2348.HK: FY PROFIT ATTRIBUTABLE RMB564.9 MILLION FY REVENUE RMB1.06 BILLION PAYMENT OF FINAL DIVIDEND OF HK$0.048 PER SHARE FOR YEAR Further company coverage: 2348.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO